Unlocking the human inner ear for therapeutic intervention
An international team of surgeons and scientists from, among others, Uppsala University has confirmed secure surgical access to the central core of the human cochlea.
Nov 8, 2022
0
60
An international team of surgeons and scientists from, among others, Uppsala University has confirmed secure surgical access to the central core of the human cochlea.
Nov 8, 2022
0
60
A new treatment for neurological and psychiatric diseases, that works by reducing the excitability of overactive brain cells, has been developed by UCL researchers.
Nov 3, 2022
0
27
Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are part of an international team that has discovered 61 additional genetic loci associated with stroke and six genes that ...
Oct 5, 2022
0
46
About three quarters of women will experience uterine fibroids before they reach the age of 50. With a range of often debilitating symptoms including excessive menstrual bleeding, they are the most common reason women undergo ...
Sep 28, 2022
0
97
A Ludwig Cancer Research study has identified a combination of three existing drugs that significantly extends survival in mouse models of the lethal brain cancer glioblastoma multiforme (GBM).
Sep 20, 2022
0
40
Alveolar rhabdomyosarcoma is a type of rare pediatric tumor. For more than 40 years there have not been any new developments regarding treatment. Research led by Prof. Dr. Anton Henssen at Charité University Berlin has now ...
Sep 19, 2022
0
85
While chemotherapy drugs can be lifesaving, they don't work for all patients or for all cancers. But a team of UTM researchers is looking at new ways to use special types of light to target cancer cells resistant to current ...
Sep 14, 2022
0
85
The billions of immune cells that help protect us from diseases do amazing things, but sometimes they need a little boost. For decades, scientists have been trying to figure out ways to engineer living immune cells to better ...
Sep 10, 2022
0
147
Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by Harvard T.H. Chan School of ...
Aug 31, 2022
0
61
Desperate times call for desperate measures, says an ancient proverb, but whoever coined it surely could not have imagined that it would hold so true on such small scales. About half a century ago, scientists found that when ...
Aug 31, 2022
0
65